Ikon Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-11-2024
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.72 Cr
as on 17-11-2024
- Satisfied Charges ₹ 7.90 Cr
as on 17-11-2024
- Revenue -8.85%
(FY 2023)
- Profit -7.27%
(FY 2023)
- Ebitda -11.02%
(FY 2023)
- Net Worth 27.38%
(FY 2023)
- Total Assets 4.97%
(FY 2023)
About Ikon Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.72 Cr. The company has closed loans amounting to ₹7.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Kingrani and Rajesh Chandrabhan serve as directors at the Company.
- CIN/LLPIN
U24230MH2002PTC137489
- Company No.
137489
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ikon Remedies Private Limited offer?
Ikon Remedies Private Limited offers a wide range of products and services, including Multivitamin Syrup & Drops, Multivitamin Drops, Digestive System Drugs & Medicines, Antacid Drugs, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Antiseptic Mouthwashes.
Who are the key members and board of directors at Ikon Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Chandrabhan  | Director | 07-Oct-2002 | Current |
| Mahesh Kingrani | Director | 07-Oct-2002 | Current |
Financial Performance of Ikon Remedies.
Ikon Remedies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.85% decrease. The company also saw a slight decrease in profitability, with a 7.27% decrease in profit. The company's net worth Soared by an impressive increase of 27.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ikon Remedies?
In 2023, Ikon Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innovative Pharmaceuticals Private LimitedActive 4 years 5 monthsMahesh Kingrani and Rajesh Chandrabhan are mutual person
Oak Sterling Vista LlpActive 1 year 7 monthsMahesh Kingrani and Rajesh Chandrabhan are mutual person
- Searle Remedies LimitedActive 12 years 6 months
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
- Hathway Wellness Private LimitedActive 4 years 8 months
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
- Iosis Remedies Private LimitedActive 4 years 6 months
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
- Pure Organic Products Private LimitedActive 1 year 1 month
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Nov 2021 | ₹2.20 M | Open |
State Bank Of India Creation Date: 25 Jan 2010 | ₹3.00 Cr | Open |
Akola Urban Co-Op Bank Ltd. Creation Date: 28 Aug 2003 | ₹2.50 M | Open |
How Many Employees Work at Ikon Remedies?
Ikon Remedies has a workforce of 45 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ikon Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikon Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
